Search - tctmd.com

Displaying 121 - 140 of 6141

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1134: Long term outcomes of TAVR in Bicuspid aortic valve based on morphology

Presenter: Abhijeet Dhoble

October 26, 2025

Presentation TCT 2025

TCT 1909: Emergent TAVR for Aortic Valve Entrapment Following Branched TEVAR in Complex Aortic Disease

Presenter: Hunter Edward Launer

October 26, 2025

Presentation TCT 2025

TCT 1131: Calcium Paradox: Impact of Low Aortic Valve Calcium on 1-year post-TAVR mortality in Bicuspid Aortic Valve Patients

Presenter: Xena Moore

October 26, 2025

Presentation TCT 2025

TCT 1129: The long-term outcomes of VitaFlow transcatheter valve system in the treatment of high surgical risk patients with severe aortic stenosis(VITAL trial)：bicuspid versus tricuspid valve

Presenter: Shasha Chen

October 26, 2025

Presentation TCT 2025

TCT 1136: Predictors of Aortic Regurgitation and clinical outcomes in Bicuspid Aortic Valve

Presenter: Ken Chan

October 26, 2025

Presentation TCT 2025

TCT 1135: Safety and efficacy of Transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type-0 bicuspid aortic valve stenosis patients

Presenter: Dejing Feng

October 26, 2025

Presentation TCT 2025

TCT 1137: Longitudinal Changes in Ascending Aortic Size After TAVR in Bicuspid Valves: The Role of Valve Morphology and Imaging Modality

Presenter: Iad Alhallak

October 26, 2025

Presentation TCT 2025

TCT 1139: Predicting short-term and long-term outcomes in bicuspid aortic valve using a novel calcium scoring methodology

Presenter: Ken Chan

October 26, 2025

Presentation TCT 2025

TCT 1138: Calcium Cataclysm: TAVR Outcomes in Patients with Extreme Calcium Scores in Bicuspid Aortic Valve

Presenter: Xena Moore

October 26, 2025

Presentation TCT 2025

TCT 1140: Stent Frame Deformation of Self-Expanding TAVR in Bicuspid Aortic Stenosis and Impact on Valve Performance

Presenter: Gabriela Tirado-Conte

October 26, 2025

Presentation TCT 2025

TCT 317: Impact of Very Severe Aortic Stenosis on Periprocedural Stroke Risk After Transcatheter Aortic Valve Replacement

Presenter: Jung-Joon Cha

October 26, 2025

Presentation TCT 2025

TCT 319: Short -Term Clinical Effect of Cerebral Embolic Protection Device Following Transcatheter Aortic-Valve Replacement in Korea Population: The Sentinel Registry (Sentinel)

Presenter: Han Su Park

October 26, 2025

Presentation TCT 2025

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Hasan Ilyas

October 26, 2025

Presentation TCT 2025

TCT 1412: Transcatheter Aortic Valve Replacement (TAVR) in a Case With Calcified Right-Dominant Double Aortic Arch

Presenter: Kuan Yu Lin

October 26, 2025

Presentation TCT 2025

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mostafa Ali

October 26, 2025

Presentation TCT 2025

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

Presenter: Mahsa Rezasoltani

October 26, 2025

Presentation TCT 2025

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

Presenter: Hasnan M. Ijaz

October 26, 2025

Presentation TCT 2025

TCT 1381: TAV in TAV in TAV: Balloon Expandable Valve for Failed Self Expanding Inside of Self Expanding TAVR Valve

Presenter: Robert Stoler

October 26, 2025

Presentation TCT 2025

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Presenter: Chaitanya Tumuluri

October 26, 2025

Presentation TCT 2025

TCT 1408: Transcatheter Aortic Valve Replacement (TAVR) and the Left Main Challenge: Risk Stratification and Bailout Strategies

Presenter: Enhua Wang

October 26, 2025

Advertisement

TCT 1134: Long term outcomes of TAVR in Bicuspid aortic valve based on morphology

TCT 1909: Emergent TAVR for Aortic Valve Entrapment Following Branched TEVAR in Complex Aortic Disease

TCT 1131: Calcium Paradox: Impact of Low Aortic Valve Calcium on 1-year post-TAVR mortality in Bicuspid Aortic Valve Patients

TCT 1129: The long-term outcomes of VitaFlow transcatheter valve system in the treatment of high surgical risk patients with severe aortic stenosis(VITAL trial)：bicuspid versus tricuspid valve

TCT 1136: Predictors of Aortic Regurgitation and clinical outcomes in Bicuspid Aortic Valve

TCT 1135: Safety and efficacy of Transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type-0 bicuspid aortic valve stenosis patients

TCT 1137: Longitudinal Changes in Ascending Aortic Size After TAVR in Bicuspid Valves: The Role of Valve Morphology and Imaging Modality

TCT 1139: Predicting short-term and long-term outcomes in bicuspid aortic valve using a novel calcium scoring methodology

TCT 1138: Calcium Cataclysm: TAVR Outcomes in Patients with Extreme Calcium Scores in Bicuspid Aortic Valve

TCT 1140: Stent Frame Deformation of Self-Expanding TAVR in Bicuspid Aortic Stenosis and Impact on Valve Performance

TCT 317: Impact of Very Severe Aortic Stenosis on Periprocedural Stroke Risk After Transcatheter Aortic Valve Replacement

TCT 319: Short -Term Clinical Effect of Cerebral Embolic Protection Device Following Transcatheter Aortic-Valve Replacement in Korea Population: The Sentinel Registry (Sentinel)

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

TCT 1412: Transcatheter Aortic Valve Replacement (TAVR) in a Case With Calcified Right-Dominant Double Aortic Arch

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

TCT 1381: TAV in TAV in TAV: Balloon Expandable Valve for Failed Self Expanding Inside of Self Expanding TAVR Valve

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

TCT 1408: Transcatheter Aortic Valve Replacement (TAVR) and the Left Main Challenge: Risk Stratification and Bailout Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content